Cargando…

Salivary duct carcinoma of the parotid gland

Salivary duct carcinoma of the parotid gland is an uncommon tumor, highly aggressive. About 200 cases have been reported in the English literature. Pathomorphologically, these tumors showed great similarities to ductal carcinoma of the female breast, which is why they described this tumor as “saliva...

Descripción completa

Detalles Bibliográficos
Autores principales: Mlika, Mona, Kourda, Nadia, Zidi, YSH, Aloui, Raoudha, Zneidi, Nadia, Rammeh, Soumaya, Zermani, Rachida, Jilani, Sarah Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303509/
https://www.ncbi.nlm.nih.gov/pubmed/22434951
http://dx.doi.org/10.4103/0973-029X.92992
_version_ 1782226742490955776
author Mlika, Mona
Kourda, Nadia
Zidi, YSH
Aloui, Raoudha
Zneidi, Nadia
Rammeh, Soumaya
Zermani, Rachida
Jilani, Sarah Ben
author_facet Mlika, Mona
Kourda, Nadia
Zidi, YSH
Aloui, Raoudha
Zneidi, Nadia
Rammeh, Soumaya
Zermani, Rachida
Jilani, Sarah Ben
author_sort Mlika, Mona
collection PubMed
description Salivary duct carcinoma of the parotid gland is an uncommon tumor, highly aggressive. About 200 cases have been reported in the English literature. Pathomorphologically, these tumors showed great similarities to ductal carcinoma of the female breast, which is why they described this tumor as “salivary duct carcinoma.” The authors describe a new case of salivary duct carcinoma of the parotid gland. We present the case of a 50-year-old patient with progressive facial paralysis. The MRI examination of the head showed two ill-defined formations. A malignant tumor was strongly suspected, so that a total left parotidectomy with excision of the adjacent facial nerve and left lymph node dissection was performed. Microscopic examination concluded to a salivary duct carcinoma of the left parotid gland negative with Her2/neu antibody with lymph node metastasis. There were no recurrences or metastases within 3 years of follow-up. Salivary duct carcinoma of the parotid gland is a rare tumor with an aggressive behavior. This is due to its propensity to infiltrate distant organs. The diagnosis is based on microscopic examination. Treatment modalities are non-consensual, but some authors advocate the necessity of aggressive approach, especially in tumors negative with Heur2/neu antibody. This is due to the fact that the overexpression of this antigen was reported to be associated with a poor prognosis.
format Online
Article
Text
id pubmed-3303509
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33035092012-03-20 Salivary duct carcinoma of the parotid gland Mlika, Mona Kourda, Nadia Zidi, YSH Aloui, Raoudha Zneidi, Nadia Rammeh, Soumaya Zermani, Rachida Jilani, Sarah Ben J Oral Maxillofac Pathol Case Report Salivary duct carcinoma of the parotid gland is an uncommon tumor, highly aggressive. About 200 cases have been reported in the English literature. Pathomorphologically, these tumors showed great similarities to ductal carcinoma of the female breast, which is why they described this tumor as “salivary duct carcinoma.” The authors describe a new case of salivary duct carcinoma of the parotid gland. We present the case of a 50-year-old patient with progressive facial paralysis. The MRI examination of the head showed two ill-defined formations. A malignant tumor was strongly suspected, so that a total left parotidectomy with excision of the adjacent facial nerve and left lymph node dissection was performed. Microscopic examination concluded to a salivary duct carcinoma of the left parotid gland negative with Her2/neu antibody with lymph node metastasis. There were no recurrences or metastases within 3 years of follow-up. Salivary duct carcinoma of the parotid gland is a rare tumor with an aggressive behavior. This is due to its propensity to infiltrate distant organs. The diagnosis is based on microscopic examination. Treatment modalities are non-consensual, but some authors advocate the necessity of aggressive approach, especially in tumors negative with Heur2/neu antibody. This is due to the fact that the overexpression of this antigen was reported to be associated with a poor prognosis. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3303509/ /pubmed/22434951 http://dx.doi.org/10.4103/0973-029X.92992 Text en Copyright: © Journal of Oral and Maxillofacial Pathology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mlika, Mona
Kourda, Nadia
Zidi, YSH
Aloui, Raoudha
Zneidi, Nadia
Rammeh, Soumaya
Zermani, Rachida
Jilani, Sarah Ben
Salivary duct carcinoma of the parotid gland
title Salivary duct carcinoma of the parotid gland
title_full Salivary duct carcinoma of the parotid gland
title_fullStr Salivary duct carcinoma of the parotid gland
title_full_unstemmed Salivary duct carcinoma of the parotid gland
title_short Salivary duct carcinoma of the parotid gland
title_sort salivary duct carcinoma of the parotid gland
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303509/
https://www.ncbi.nlm.nih.gov/pubmed/22434951
http://dx.doi.org/10.4103/0973-029X.92992
work_keys_str_mv AT mlikamona salivaryductcarcinomaoftheparotidgland
AT kourdanadia salivaryductcarcinomaoftheparotidgland
AT zidiysh salivaryductcarcinomaoftheparotidgland
AT alouiraoudha salivaryductcarcinomaoftheparotidgland
AT zneidinadia salivaryductcarcinomaoftheparotidgland
AT rammehsoumaya salivaryductcarcinomaoftheparotidgland
AT zermanirachida salivaryductcarcinomaoftheparotidgland
AT jilanisarahben salivaryductcarcinomaoftheparotidgland